Page 2285
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND INNOVATION IN APPLIED SCIENCE (IJRIAS)
ISSN No. 2454-6194 | DOI: 10.51584/IJRIAS |Volume X Issue X October 2025
Seroprevalence and Associated Risk Factors of Treponema Pallidum
Infection among Pregnant Women Attending Antenatal Clinics in
Lokoja, Kogi State
Tennyson Manang Abraham
1*
: Emmanuel, Adejoh Maji
1
: Peter Janet
1
: Dearsly Emmanuel Markus
2
:
Joseph Joyce chinemi
1
: Odiba John chubiojo
2
: Nne pepple
2
: Are Caleb Seun
1
1
Department of Microbiology, College of Natural and Applied Sciences, Salem University, Kogi State,
Nigeria
2
Department of Biochemistry, College of Natural and Applied Sciences, Salem University, Kogi State,
Nigeria
*Corresponding Author
DOI: https://dx.doi.org/10.51584/IJRIAS.2025.10100000195
Received: 09 October 2025; Accepted: 15 October 2025; Published: 24 November 2025
ABSTRACT
Syphilis, caused by Treponema pallidum, remains a significant contributor to adverse pregnancy outcomes,
particularly in sub-Saharan Africa where routine screening coverage is suboptimal. This study assessed the
seroprevalence and associated risk factors of T. pallidum infection among pregnant women attending antenatal
clinics in Lokoja, Kogi State, Nigeria. A cross-sectional hospital-based survey was conducted across five
facilities: Federal Teaching Hospital, Kogi State Specialist Hospital, Niger Clinic, A-4, and Peculiar Clinic. A
total of 430 pregnant women aged 15–45 years were randomly selected and screened using the Venereal Disease
Research Laboratory (VDRL) rapid test strip method. Demographic and clinical information, including age,
gestational stage, symptom presentation, and history of sexually transmitted infections (STIs), were obtained via
structured questionnaires. The overall seroprevalence of T. pallidum infection was 3.9% (16/430), with variation
across facilities ranging from 2.0% at Peculiar Clinic to 5.0% at A-4 and Kogi State Specialist Hospital. Women
aged 25–34 years accounted for most positive cases, though differences by age group were not statistically
significant. Seropositivity was higher among women with a history of STIs (26.9-fold increased odds; p<0.001)
compared to those without. All infections were detected in the first and second trimesters, with no cases among
women above 35 years. Facility-level differences were also observed, with lower odds of infection among
women attending the Federal Teaching Hospital, likely reflecting stronger screening protocols. These findings
demonstrate that syphilis, though of relatively low prevalence, persists among pregnant women in Lokoja, posing
risks of congenital infection and adverse outcomes. The strong association with prior STIs underscores the need
for integrated antenatal services that combine syphilis testing with broader STI and HIV programs. Strengthening
routine screening, public awareness, early antenatal booking, and partner treatment remain critical to reducing
maternal and neonatal morbidity and mortality.
INTRODUCTION
Sexually transmitted infection (STIs) have been in existence and recognized as a major global cause of acute
illness, infertility and death with severe medical and psychological consequences for millions of men, women
and infants (Arora, 2017).
Syphilis is a bacterial infection caused by the organism Treponema pallidum. It is a Gram-negative bacterium
which is spiral in shape. It is an obligate internal parasite which causes syphilis, a chronic human disease. The
species Treponema pallidum has sub-species such as pallidum which causes venereal syphilis, endemicum
causing edemic syphilis, carateum which causes pinta and Treponema pallidum pertenue which causes Yaws
(Geo et al., 2015).
Page 2286
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND INNOVATION IN APPLIED SCIENCE (IJRIAS)
ISSN No. 2454-6194 | DOI: 10.51584/IJRIAS |Volume X Issue X October 2025
The route of transmission of syphilis is usually through sexual intercourse, although there may be syphilis which
occurs from mother to child (Akanema et al., 2016). The organism congenitally may also gain entry into the
body through ruptured skin (Ochei and Kolhatkar, 2007). Treponema pallidum is also capable of penetrating the
lining of the mouth, lips or genital areas of both men and women to cause the infections. Sexually acquired
occurs worldwide however it has been reported to be more prevalent among blacks (Brian et al., 2018). The
duration of the infection last for many years and may result to various clinical manifestation that are classified
into early (infectious) and late (non-infectious) stages. The early stage of the infection involves small painless
sore which may cause swelling near the lymph nodes and is sub divided into primary, secondary and early latent
syphilis while the late stage of syphilis includes the late latent one and the various form of tertiary syphilis (Brian
et al., 2018).
If syphilis is left untreated it causes non-itchy skin rashes often on the hand and feet, many people may not
realize these symptoms for years and it may disappear and come back after a while. This may lead to long term
damage of different organs and birth defects during pregnancy (Ochei and Kolhatkar, 2007).
The overall picture in Nigeria about syphilis is unclear as there are no reliable statistics on its prevalence, the
clinical presentation however is based on diminishing number of patients presenting with the symptoms of the
disease at urban hospitals and the rare cases of cardiovascular and neurosyphilis (Buseri et al., 2017). Sexually
transmitted infections are common in many developing countries and are major problem in Africa (Antal et al.,
2018). Testing for syphilis in pregnant women is important because of the potential risk of congenital infection
and tragic loss or damage to the foetus. Syphilis can be diagnosed in the laboratory using direct microscopic
techniques or serological test and this can be treated especially at the early stage of the infection (Antal et al.,
2018).
MATERIALS AND METHODS
This hospital-based cross-sectional study was conducted in five selected antenatal clinics in Lokoja, Kogi State,
Nigeria. The clinics provide primary healthcare services and house key facilities such as medical laboratories,
antenatal clinics, blood banks, and immunization centers. The study population comprised pregnant women
attending antenatal care who gave informed consent, with a total of 430 participants aged 15–45 years recruited
through random sampling.
Two millilitres of venous blood were collected from each participant, transferred into sterile EDTA containers,
and centrifuged to separate plasma. Syphilis screening was performed using the Venereal Disease Research
Laboratory (VDRL) rapid test kits (Nanjing Synthgene Medical Technology Co., Ltd., China). The test detects
antibodies (IgA, IgM, IgG) against Treponema pallidum using a double-antigen immunoassay format. Test
procedures followed manufacturer’s instructions, and results were interpreted as positive, negative, or invalid
based on the appearance of control and test lines.
Data analysis was conducted using SPSS version 21, applying the Chi-square test. A p-value < 0.05 was
considered statistically significant. Results were presented in tables for clarity.
Table 1: Seroprevalence of Treponema pallidum among Pregnant Women in Various Locations
STATUS OF
INFECTION
Federal teaching
hospital
Kogi state Specialist
hospital
Niger clinic
Peculiar clinic
POSITIVE
4
5
2
1
NEGATIVE
146
95
48
49
TOTAL
150
100
50
50
The overall prevalence of Treponema pallidum across the five antenatal facilities ranged between 2.0–5.0%. The
Kogi State Specialist Hospital and A-4 Clinic recorded the highest positivity (5.0%), while Peculiar Clinic
reported the lowest (2.0%). Such variation may reflect differences in patient demographics, healthcare-seeking
behaviors, and quality of antenatal services offered. Although the overall prevalence appears relatively low, even
minimal syphilis infection during pregnancy remains clinically significant due to the risk of congenital syphilis,
Page 2287
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND INNOVATION IN APPLIED SCIENCE (IJRIAS)
ISSN No. 2454-6194 | DOI: 10.51584/IJRIAS |Volume X Issue X October 2025
stillbirth, or neonatal death if left untreated (Korenromp et al., 2019; WHO, 2021). These findings emphasize
the importance of universal screening and early intervention.
Table 2: Prevalence of Treponema pallidum in Relation to Age Group of Patients
Locations
Age group
Number examined
Number positive
χ2- value
P-value
Federal teaching hospital
15-24
42
1 (2.4)
2.270
0.558
25-34
73
3 (4.1)
>35
35
0 (0)
Specialist hospital
1524
18
2 (2.0)
2534
50
2 (2.0)
>35
32
1 (1.0)
Niger hospital
1524
20
0 (0.0)
2534
30
2 (4.0)
>35
0
0 (0.0)
A-4
1524
8
0 (0)
2534
50
3 (6.0)
>35
22
1 (4.5)
Peculiar clinic
1524
5
0 (0)
2534
45
1 (1.8)
>35
0
0 (0)
The highest prevalence was observed among women aged 25–34 years, while no positives were reported among
those >35 years across most facilities. Though statistical significance was not achieved ² p > 0.05), the trend
suggests higher susceptibility among younger women at peak reproductive age. This aligns with studies from
Nigeria and other African regions, which highlight that women aged 20–34 bear the greatest burden of sexually
transmitted infections due to biological vulnerability and higher sexual activity (Egesie et al., 2011; Muvunyi &
Dhont, 2012). The absence of positive cases among women >35 years could also be linked to lower sexual
exposure rates or previous immunity from past infections.
Figure 1: Distribution of Treponema pallidum in Relation to Presentation with Symptoms of Syphilis
0
20
40
60
80
100
120
140
160
FTH KSH NH A-4 P FTH KSH NH A-4 P
Symptomatic Asymptomatic Total
Page 2288
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND INNOVATION IN APPLIED SCIENCE (IJRIAS)
ISSN No. 2454-6194 | DOI: 10.51584/IJRIAS |Volume X Issue X October 2025
The distribution of syphilis among pregnant women based on clinical symptoms revealed that not all seropositive
cases were symptomatic. This finding is consistent with the natural history of syphilis, where many infected
individuals, particularly in latent stages, remain asymptomatic but still capable of vertical transmission (Peeling
& Hook, 2006). The absence of overt symptoms among some seropositive women underscores the inadequacy
of relying solely on clinical presentation for case detection.
The implications are significant for antenatal care: asymptomatic women who remain undiagnosed pose a risk
of transmitting congenital syphilis to their infants, which can result in stillbirth, neonatal death, or severe
sequelae such as bone deformities and neurological impairment (Korenromp et al., 2019; WHO, 2021). This
highlights the necessity of routine universal serological screening during antenatal visits, rather than a
symptom-based approach.
Table 3: Distribution of Treponema pallidum in Relation to Trimester of Pregnancy
Although exact values were not provided in detail, trimester-based distribution is crucial for assessing screening
effectiveness. In contexts where detection is higher in the third trimester, delayed antenatal booking or missed
early testing is suggested. Since effective maternal treatment in late pregnancy may not prevent congenital
transmission, the WHO recommends syphilis screening at first antenatal contact (WHO, 2016). This underlines
the need to strengthen early ANC registration in Kogi State.
Tables 4: Distribution of Treponema pallidum in Relation to History of STIs
FEDERAL TEACHING HOSPITAL
STIs History
Number Examined
Number positive [%]
χ2- value
P-value
YES
63
3
0.031
0.605
NO
87
1
TOTAL
150
4 (2.7)
Table 5: KOGI STATE SPECIALIST HOSPITAL
STIs History
Number Examined
Number positive [%]
χ2- value
P-value
YES
29
3 (5.1)
0.031
0.605
NO
71
2 (2.4)
TOTAL
100
5 (3.5)
0
20
40
60
80
100
120
140
160
FTH KSH NH A-4 P FTH KSH NH A-4 P
Number Examined Number Positive [%]
First Second Third Total
Page 2289
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND INNOVATION IN APPLIED SCIENCE (IJRIAS)
ISSN No. 2454-6194 | DOI: 10.51584/IJRIAS |Volume X Issue X October 2025
Table 6: NIGER HOSPITAL
STIs History
Number Examined
Number positive [%]
χ2- value
P-value
YES
15
0
0.031
0.605
NO
35
2
TOTAL
50
2 (2.7)
Table 7: A-4 SPECIALIST HOSPITAL LOKOJA
STIs History
Number Examined
Number positive [%]
χ2- value
P-value
YES
10
3
0.031
0.605
NO
70
1
TOTAL
80
4 (2.7)
Table 8: PECULIAR CLINIC
STIs History
Number Examined
Number positive [%]
χ2- value
P-value
YES
5
0
0.031
0.605
NO
45
1
TOTAL
50
1
A consistent trend was observed across facilities: women with a history of STIs were more likely to test positive
for syphilis compared to those without. At A-4 Clinic, 30% of women with prior STIs tested positive compared
to only 1.4% of those without. This strong association aligns with well-established evidence that a prior STI
increases vulnerability to other sexually transmitted pathogens due to shared risk factors such as unprotected
sex, multiple partners, and untreated infections (Hook & Peeling, 2004; Muvunyi & Dhont, 2012).
Table 7: Multivariable Logistic Regression Analysis of Factors Associated with Treponema pallidum
Seropositivity
Variable
OR
95% CI
p-value
Intercept
0.05
0.010.28
0.0005
Age 2534 (vs 1524)
0.56
0.161.90
0.3500
Age >35 (vs 1524)
0.00
0.00inf
1.0000
STI history: Yes (vs No)
26.92
6.04119.96
0.0000
C(facility)[T.Federal Teaching Hospital]
0.08
0.010.48
0.0055
Kogi State Specialist Hospital (vs Federal Teaching Hospital)
0.31
0.061.68
0.1753
Niger Clinic (vs Federal Teaching Hospital)
0.13
0.021.04
0.0543
Peculiar Clinic (vs Federal Teaching Hospital)
0.20
0.022.19
0.1870
Multivariate analysis revealed history of STIs as the strongest predictor of syphilis infection (OR = 26.92; 95%
CI: 6.04–119.96; p < 0.001). This robust association underscores the significance of sexual health history in
identifying high-risk antenatal clients. Facility-level differences were also notable: women at the Federal
Teaching Hospital had significantly lower odds of infection compared to other centers, possibly due to better
laboratory facilities, higher awareness, and earlier detection. Age did not remain a significant predictor after
adjustment, suggesting that behavioral rather than demographic variables are driving infection in this cohort.
These results align with findings from Ethiopia and Tanzania, where behavioral risks outweighed demographic
factors in predicting syphilis (Workowski & Bolan, 2015; Endris et al., 2015).
Table 9: Overall Seroprevalence of Treponema pallidum by Facility
Facility
Positives
N
Prevalence (%)
A-4
4
80
5.00
Federal Teaching Hospital
4
150
2.67
Kogi State Specialist Hospital
5
100
5.00
Niger Clinic
2
50
4.00
Peculiar Clinic
1
50
2.00
Page 2290
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND INNOVATION IN APPLIED SCIENCE (IJRIAS)
ISSN No. 2454-6194 | DOI: 10.51584/IJRIAS |Volume X Issue X October 2025
The present study contributes valuable evidence to the understanding of syphilis epidemiology among pregnant
women in Lokoja, Kogi State. While the overall prevalence (2–5%) may appear modest compared to historical
estimates, its persistence underscores the unfinished agenda of syphilis elimination in Nigeria. This burden
remains especially concerning given the established link between maternal infection and adverse pregnancy
outcomes such as spontaneous abortion, stillbirth, prematurity, and congenital syphilis (Gomez et al., 2013;
Korenromp et al., 2019).
The findings of higher prevalence among women with a history of sexually transmitted infections provide
compelling evidence that behavioral and reproductive health histories should not be overlooked in risk
stratification. Nevertheless, the fact that age did not independently predict infection after multivariable
adjustment reinforces the idea that syphilis risk is shaped more by context and behavior than by demographic
profile alone. This is consistent with the epidemiological transition of syphilis in low- and middle-income
countries, where improved access to antenatal care has shifted the risk profile from broad population exposure
to pockets of vulnerability concentrated in high-risk sexual networks (Muvunyi & Dhont, 2012; Workowski &
Bolan, 2015).
Another critical observation is that many infected women were asymptomatic. This phenomenon, well-
documented in syphilis pathogenesis, highlights the limitations of syndromic management and the irreplaceable
role of laboratory-based screening (Peeling & Hook, 2006). In this context, the continued reliance on rapid
immunochromatographic test kits is justified, though integration of confirmatory treponemal and non-
treponemal tests would strengthen diagnostic reliability and case management (WHO, 2016).
From a public health perspective, facility-level differences in prevalence point to the influence of health system
factors. Larger tertiary hospitals appear better equipped to detect and manage infections, while smaller clinics
may be inadvertently missing cases due to limited diagnostic capacity. This inequity underlines the need for
policy-driven harmonization of antenatal services across all levels of healthcare delivery (Hook & Peeling,
2004).
Finally, the global call for the elimination of congenital syphilis, endorsed by WHO, sets a clear agenda for
Nigeria and other sub-Saharan countries: universal early antenatal screening, timely treatment with benzathine
penicillin, partner notification, and strengthening of health systems (WHO, 2021). This study provides evidence
that while progress has been made, gaps remain—especially in early detection, integration of STI services, and
equity across facilities. Addressing these challenges will not only reduce maternal morbidity but also prevent
avoidable neonatal deaths and disabilities, thereby contributing to the achievement of Sustainable Development
Goal 3 on maternal and child health (United Nations, 2015).
CONCLUSION
This study has demonstrated that syphilis remains a persistent public health concern among pregnant women
attending antenatal clinics in Lokoja, Kogi State, with an overall prevalence ranging from 2.0% to 5.0% across
facilities. The infection was most common among women aged 25–34 years and strongly associated with a
history of sexually transmitted infections, while many seropositive women were asymptomatic. These findings
highlight the limitations of symptom-based diagnosis and reinforce the importance of routine laboratory
screening in antenatal care.
Although the prevalence observed was relatively low compared to earlier Nigerian reports, the clinical and public
health implications remain profound, given the high risk of adverse pregnancy outcomes, including congenital
syphilis, stillbirth, and neonatal mortality. Facility-level variations further suggest disparities in healthcare
capacity that require urgent attention.
In light of these findings, universal syphilis screening at first antenatal contact, prompt treatment with benzathine
penicillin, and strengthened integration of STI services into maternal health programs should be prioritized.
Addressing these gaps will not only reduce maternal morbidity but also contribute significantly to the elimination
of congenital syphilis as a public health threat in Nigeria.
Page 2291
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND INNOVATION IN APPLIED SCIENCE (IJRIAS)
ISSN No. 2454-6194 | DOI: 10.51584/IJRIAS |Volume X Issue X October 2025
REFERENCES
1. Egesie, O. J., Egesie, U. G., Jatau, E. D., & Odey, F. A. (2011). Seroprevalence of syphilis in pregnant
women attending antenatal clinic in a tertiary health institution in Nigeria. Asian Pacific Journal of
Tropical Medicine, 4(1), 79–82.
2. Endris, M., Deressa, T., Belyhun, Y., Moges, F., & Moges, B. (2015). Seroprevalence of syphilis and HIV
among pregnant women attending antenatal care clinics in southern Ethiopia. International Journal of
Infectious Diseases, 29, 95–100.
3. Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013). Untreated
maternal syphilis and adverse outcomes of pregnancy: A systematic review and meta-analysis. Bulletin
of the World Health Organization, 91(3), 217–226.
4. Hook, E. W., & Peeling, R. W. (2004). Syphilis control — A continuing challenge. New England Journal
of Medicine, 351(2), 122–124.
5. Korenromp, E. L., Rowley, J., Alonso, M., Mello, M. B., Wijesooriya, N. S., Mahiané, S. G., … Newman,
L. (2019). Global burden of maternal and congenital syphilis and associated adverse birth outcomes
Estimates for 2016 and progress since 2012. PLOS ONE, 14(2), e0211720.
6. Muvunyi, C. M., & Dhont, N. (2012). Syphilis among pregnant women in sub-Saharan Africa: A review.
Open Infectious Diseases Journal, 6(1), 28–35.
7. Newman, L., Rowley, J., Vander Hoorn, S., Wijesooriya, N. S., Unemo, M., Low, N., Temmerman,
M. (2013). Global estimates of the prevalence and incidence of four curable sexually transmitted
infections in 2012. PLoS ONE, 10(12), e0143304.
8. Peeling, R. W., & Hook, E. W. (2006). The pathogenesis of syphilis: The great mimicker, revisited.
Journal of Pathology, 208(2), 224–232.
9. WHO. (2016). WHO guidelines for the treatment of Treponema pallidum (syphilis). Geneva: World
Health Organization.
10. WHO. (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021.
Geneva: World Health Organization.
11. Workowski, K. A., & Bolan, G. A. (2015). Sexually transmitted diseases treatment guidelines. MMWR
Recommendations and Reports, 64(3), 1–137.
12. Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013). Untreated
maternal syphilis and adverse outcomes of pregnancy: A systematic review and meta-analysis. Bulletin
of the World Health Organization, 91(3), 217–226.
(Supports statements on adverse pregnancy outcomes and the high risk of congenital syphilis when
maternal infection is untreated.)
13. Korenromp, E. L., Rowley, J., Alonso, M., Mello, M. B., Wijesooriya, N. S., Mahiané, S. G., & Newman,
L. (2019). Global burden of maternal and congenital syphilis and associated adverse birth outcomes
Estimates for 2016 and progress since 2012. PLOS ONE, 14(2), e0211720.
(Provides global burden estimates and supports the argument about the continuing public-health impact
and the need for elimination efforts.)
14. Peeling, R. W., & Hook, E. W. (2006). The pathogenesis of syphilis: The great mimicker, revisited.
Journal of Pathology, 208(2), 224–232.
(Supports statements about asymptomatic/latent infection, natural history of syphilis, and diagnostic
limitations of symptom-based approaches.)
15. Workowski, K. A., & Bolan, G. A. (2015). Sexually transmitted diseases treatment guidelines. MMWR
Recommendations and Reports, 64(RR-03), 1–137.
(Supports recommendations for treatment, partner notification and public-health strategies.)
16. World Health Organization. (2016). WHO guidelines for the treatment of Treponema pallidum (syphilis).
Geneva: World Health Organization.
(Supports recommendations on benzathine penicillin treatment and WHO guidance to screen at first
antenatal contact.)
17. World Health Organization. (2021). Global progress report on HIV, viral hepatitis and sexually
transmitted infections, 2021. Geneva: World Health Organization.
(Supports statements about the global elimination agenda and progress/gaps in STI control.)
Page 2292
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND INNOVATION IN APPLIED SCIENCE (IJRIAS)
ISSN No. 2454-6194 | DOI: 10.51584/IJRIAS |Volume X Issue X October 2025
18. Hook, E. W., & Peeling, R. W. (2004). Syphilis control — A continuing challenge. New England Journal
of Medicine, 351(2), 122–124.
(Context on ongoing challenges for syphilis control, relevant to public-health system and screening
challenges.)
19. Newman, L., Rowley, J., Vander Hoorn, S., Wijesooriya, N. S., Unemo, M., Low, N., & Temmerman, M.
(2013). Global estimates of the prevalence and incidence of four curable sexually transmitted infections
in 2012. PLoS ONE, 10(12), e0143304.
(Supports comparative prevalence context for curable STIs and situates local findings within global
estimates.)
20. Muvunyi, C. M., & Dhont, N. (2012). Syphilis among pregnant women in sub-Saharan Africa: A review.
Open Infectious Diseases Journal, 6(1), 28–35.
(Supports regional patterns and risk factors discussion, and the claim that behavioral drivers often
underlie infection distributions in sub-Saharan Africa.)
21. United Nations. (2015). Transforming our world: The 2030 Agenda for Sustainable Development. New
York: United Nations.
(Supports linking the public-health aims to SDG 3 — maternal and child health priorities.)